Translational Autoimmunity, Volume 2

Professor Nima Rezaei gained his medical degree (MD) from Tehran University of Medical Sciences and subsequently obtained an MSc in Molecular and Genetic Medicine and a PhD in Clinical Immunology and Human Genetics from the University of Sheffield, UK. He also spent a short-term fellowship of Pediatric Clinical Immunology and Bone Marrow Transplantation in the Newcastle General Hospital. Professor Rezaei is now the Full Professor of Immunology and Vice Dean of Research, School of Medicine, Tehran University of Medical Sciences, and the co-founder and Head of the Research Center for Immunodeficiencies. He is also the founding President of the Universal Scientific Education and Research Network (USERN). Professor Rezaei has already been the Director of more than 55 research projects and has designed and participated in several international collaborative projects. Professor Rezaei is an editorial assistant or board member for more than 30 international journals. He has edited more than 35 international books, has presented more than 500 lectures/posters in congresses/meetings, and has published more than 1,000 scientific papers in the international journals.

• 1. Introduction on therapeutic opportunities for autoimmunity2. Innate lymphoid cells as therapeutic targets in autoimmune diseases3. B regulatory cells in patients with autoimmune diseases: pathogenic significance, therapeutic potential4. Regulatory T cells in autoimmunity and potential therapeutic targets5. Application of IL-6 antagonists in autoimmune disorders6. The search for monomer interaction-based alternative TNFα therapies7. Generation of thymic cells from pluripotent stem cells for basic research and cell therapy8. The NLRP3 inflammasome pathway in autoimmune diseases: a chronotherapeutic perspective?9. Plasmocytes infiltrating autoimmune organs and their putative targeting10. Biological aging and autoimmunity11. Efficacy and safety of biologic treatment in autoimmune diseases12. Nutritional implications for the pathophysiology and treatment of autoimmune disorders13. Dysbiosis and probiotic applications in autoimmune diseases14. Precision medicine in managing chronic conditions with an immunological component15. New advanced therapy medicinal products in treatment of autoimmune diseases16. Targeting of autoimmune disorders through metal nanoformulation in overcoming the fences of conventional treatment approaches17. Immunomodulatory effects of parasites on autoimmunity18. Prediction of autoimmune diseases: from bench to bedside